Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 7 studies | 63% ± 17% |
Insufficient scRNA-seq data for expression of CCL22 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 86% | 175.35 | 496 / 578 | 88% | 13.43 | 1021 / 1155 |
breast | 64% | 104.05 | 296 / 459 | 82% | 9.53 | 921 / 1118 |
esophagus | 41% | 87.80 | 597 / 1445 | 84% | 7.44 | 153 / 183 |
bladder | 48% | 22.67 | 10 / 21 | 74% | 9.53 | 372 / 504 |
intestine | 41% | 120.07 | 393 / 966 | 76% | 6.33 | 398 / 527 |
skin | 73% | 302.48 | 1325 / 1809 | 40% | 2.93 | 191 / 472 |
prostate | 47% | 29.26 | 115 / 245 | 57% | 3.04 | 285 / 502 |
stomach | 26% | 24.75 | 93 / 359 | 76% | 7.80 | 217 / 286 |
spleen | 98% | 180.15 | 235 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 15.42 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 156.93 | 25 / 29 |
pancreas | 4% | 2.80 | 14 / 328 | 81% | 10.71 | 145 / 178 |
thymus | 24% | 29.02 | 157 / 653 | 61% | 5.80 | 370 / 605 |
uterus | 8% | 6.04 | 14 / 170 | 66% | 7.71 | 304 / 459 |
kidney | 20% | 15.18 | 18 / 89 | 31% | 1.29 | 281 / 901 |
adipose | 42% | 72.59 | 511 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 13527.34 | 280 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 20% | 16.36 | 52 / 258 | 9% | 3.23 | 21 / 230 |
ovary | 6% | 2.99 | 11 / 180 | 15% | 0.68 | 65 / 430 |
liver | 8% | 4.59 | 17 / 226 | 10% | 0.69 | 40 / 406 |
blood vessel | 11% | 18.37 | 153 / 1335 | 0% | 0 | 0 / 0 |
brain | 3% | 2.24 | 89 / 2642 | 5% | 0.36 | 33 / 705 |
heart | 5% | 3.40 | 46 / 861 | 0% | 0 | 0 / 0 |
muscle | 3% | 1.16 | 21 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0009615 | Biological process | response to virus |
GO_0006955 | Biological process | immune response |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006954 | Biological process | inflammatory response |
GO_0006935 | Biological process | chemotaxis |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0007267 | Biological process | cell-cell signaling |
GO_0048245 | Biological process | eosinophil chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CCL22 |
Protein name | C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69)] |
Synonyms | A-152E5.1 MDC SCYA22 |
Description | FUNCTION: May play a role in the trafficking of activated/effector T-lymphocytes to inflammatory sites and other aspects of activated T-lymphocyte physiology. Chemotactic for monocytes, dendritic cells and natural killer cells. Mild chemoattractant for primary activated T-lymphocytes and a potent chemoattractant for chronically activated T-lymphocytes but has no chemoattractant activity for neutrophils, eosinophils, and resting T-lymphocytes. Binds to CCR4. Processed forms MDC(3-69), MDC(5-69) and MDC(7-69) seem not be active. |
Accessions | O00626 ENST00000219235.5 |